Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: BONE MORPHOGENETIC PROTEINS - BLOOD , . Treffer: 4
2015
Muschitz, C; Kocijan, R; Pahr, D; Patsch, JM; Amrein, K; Misof, BM; Kaider, A; Resch, H; Pietschmann, P
Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis.
Calcif Tissue Int. 2015; 96(6): 477-489.
Doi: 10.1007/s00223-015-0003-8
Web of Science
PubMed
FullText
FullText_MUG
2014
Amrein, K; Dobnig, H; Wagner, D; Piswanger-Sölkner, C; Pieber, TR; Pilz, S; Tomaschitz, A; Dimai, HP; Fahrleitner-Pammer, A
Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
J Am Geriatr Soc. 2014; 62(6):1023-1029
Doi: 10.1111/jgs.12791
Web of Science
PubMed
FullText
FullText_MUG
Kocijan, R; Muschitz, C; Fahrleitner-Pammer, A; Amrein, K; Pietschmann, P; Haschka, J; Dinu, S; Kapiotis, S; Resch, H
Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.
J Clin Endocrinol Metab. 2014; 99(2):E311-E319
Doi: 10.1210/jc.2013-2244
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Amrein, K; Amrein, S; Drexler, C; Dimai, HP; Dobnig, H; Pfeifer, K; Tomaschitz, A; Pieber, TR; Fahrleitner-Pammer, A
Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
J Clin Endocrinol Metab. 2012; 97(1):148-154
Doi: 10.1210/jc.2011-2152
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG